BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20084775)

  • 1. Uterine sarcoma: 14 years experience in KCCC.
    Al Wakiel H; Ragheb AM; Varghese A; Juzeer A; Vashista S; Albasmy A
    Gulf J Oncolog; 2008 Jul; (4):45-51. PubMed ID: 20084775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
    Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
    Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].
    Calais G; Frinot-Rousseau S; Body G; Fetissoff F; Le Floch O; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):885-9. PubMed ID: 2614028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of patients with sarcoma of the uterus].
    Bokhman IaV; Urmancheeva AF
    Vopr Onkol; 1989; 35(10):1245-51. PubMed ID: 2596071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adjuvant radiation in uterine sarcomas.
    Sampath S; Schultheiss TE; Ryu JK; Wong JY
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of patients with uterine sarcomas.
    Sharma DN; Rath GK; Kumar S; Kumar L; Bhatla N; Gandhi AK; Hariprasad R
    J Cancer Res Ther; 2011; 7(3):270-4. PubMed ID: 22044806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of surgery and treatment trends in uterine sarcoma.
    Benoit L; Arnould L; Cheynel N; Goui S; Collin F; Fraisse J; Cuisenier J
    Eur J Surg Oncol; 2005 May; 31(4):434-42. PubMed ID: 15837053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].
    Coquard R; Romestaing P; Ardiet JM; Mornex F; Sentenac I; Gérard JP
    Bull Cancer; 1997 Jun; 84(6):625-9. PubMed ID: 9295866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of 105 cases with uterine sarcoma.
    Yoney A; Eren B; Eskici S; Salman A; Unsal M
    Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma.
    Barney BM; Petersen IA; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):191-7. PubMed ID: 21985942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
    Weitmann HD; Kucera H; Knocke TH; Pötter R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adjuvant pelvic radiotherapy in stage I uterine sarcoma.
    Magnuson WJ; Petereit DG; Anderson BM; Geye HM; Bradley KA
    Anticancer Res; 2015 Jan; 35(1):365-70. PubMed ID: 25550573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.